MicroRNAs and Bariatric/Metabolic Surgery: Biomarkers, Mediators of Metabolic Remission, or Both?
Obesities · 30.07.2026 · 6 (4) · 56
DOI: 10.3390/obesities6040056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesities, online erschienen am 30.07.2026. Verfasst von Antonina Gerganova-Sirakova und 13 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian National Science Fund.
Abstract (Originalsprache)
Purpose of Review: Obesity is a growing global health challenge, with severe obesity projected to affect up to 25% of individuals with obesity by 2030. Bariatric surgery remains the most effective treatment, yet the molecular mechanisms underlying its metabolic benefits are not fully understood. This review summarizes current evidence on the role of microRNAs in bariatric/metabolic surgery and evaluates their potential as biomarkers and therapeutic targets. Recent Findings: Bariatric surgery induces significant alterations in circulating and tissue-specific miRNA profiles, particularly those involved in glucose metabolism, inflammation, and adipose tissue remodeling. Among the most frequently reported candidates, miR-122, miR-221, miR-27a, miR-126, miR-144, miR-222, miR-223, miR-375, miR-92a, and miR-155 have been associated with weight loss, improved insulin sensitivity, and diabetes remission. Emerging data suggest that these miRNAs may act not only as biomarkers of metabolic recovery but also as regulators of insulin signaling, inflammatory pathways, and adipocyte function. Summary: Current evidence supports a role for miRNAs in the metabolic adaptations observed after bariatric surgery. Although further validation is required, miRNAs show promise as minimally invasive biomarkers for predicting and monitoring treatment response and may provide insight into the molecular mechanisms underlying obesity remission and improvement of obesity-related comorbidities.
Förderung
- Bulgarian National Science Fund
Zitieren
APA
Gerganova-Sirakova, A., Grozdev, K., Gateva, A., Kaneva, R., Nedeva, I., Assyov, Y., Karamfilova, V., Gatev, T., Kachakova-Yordanova, D., Petkova, V., Bozhilova, R., Kyurkchiyan, S., Sirakova, K., & Kamenov, Z. (2026). MicroRNAs and Bariatric/Metabolic Surgery: Biomarkers, Mediators of Metabolic Remission, or Both?. Obesities, 6(4), 56. https://doi.org/10.3390/obesities6040056
Vancouver
Gerganova-Sirakova A, Grozdev K, Gateva A, Kaneva R, Nedeva I, Assyov Y, et al. MicroRNAs and Bariatric/Metabolic Surgery: Biomarkers, Mediators of Metabolic Remission, or Both?. Obesities. 2026;6(4):56. doi:10.3390/obesities6040056
BibTeX
@article{GerganovaSirakova2026,
author = {Gerganova-Sirakova, Antonina and Grozdev, Konstantin and Gateva, Antoaneta and Kaneva, Radka and Nedeva, Iveta and Assyov, Yavor and Karamfilova, Vera and Gatev, Tsvetan and Kachakova-Yordanova, Darina and Petkova, Veronika and Bozhilova, Radosveta and Kyurkchiyan, Silva and Sirakova, Kristina and Kamenov, Zdravko},
title = {MicroRNAs and Bariatric/Metabolic Surgery: Biomarkers, Mediators of Metabolic Remission, or Both?},
journal = {Obesities},
year = {2026},
volume = {6},
number = {4},
pages = {56},
doi = {10.3390/obesities6040056}
}
EUVIMED